Novel gene activated in rat insulinomas

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• Insulinomas are pancreatic tumors that can be experimentally induced.
• Polyadenosine diphosphate (polyADP)-ribose synthetase inhibitors are used alongside diabetogenic agents to induce these tumors in animal models.

Purpose of the Study:

• To identify novel genes involved in the development of experimentally induced insulinomas.
• To investigate the expression patterns of newly discovered genes in both normal and tumor pancreatic tissues.

Main Methods:

• Construction of a complementary DNA (cDNA) library from streptozocin-nicotinamide-induced rat insulinomas.
• Sequencing and analysis of the cDNA library to identify novel genes.
• Gene expression analysis using techniques like RT-PCR or Northern blotting in various insulinoma models and normal pancreatic islets.

Main Results:

• A novel gene, designated rat insulinoma gene (rig), encoding a 145-amino acid basic protein, was identified.
• The rig gene was found to be expressed in both streptozocin-nicotinamide and alloxan-nicotinamide induced insulinomas.
• No expression of the rig gene was detected in normal pancreatic islets or in regenerating islets.

Conclusions:

• The activation of the rat insulinoma gene (rig) is associated with pancreatic beta-cell transformation.
• Rig gene expression may serve as a general marker for the development of insulinomas.
• Further research into the function of the rig gene could elucidate mechanisms of beta-cell tumorigenesis.